Skip to search formSkip to main contentSkip to account menu

Mean Platelet Component Measurement

Known as: MPC, Mean Platelet Component 
The determination of the amount of mean platelet component present in a sample.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
A distributed model predictive control based load frequency control scheme for multi-area interconnected power system using discrete-time Laguerre functions.
Highly Cited
2014
Highly Cited
2014
Finite element based model predictive control for active vibration suppression of a one-link flexible manipulator.
Highly Cited
2012
Highly Cited
2012
Directional Spreads of Dense Multipath Components in Indoor Environments: Experimental Validation of a Ray-Tracing Approach
This paper investigates the prediction capabilities of a Ray-Tracing tool with advanced features, i.e., diffuse scattering and… 
Highly Cited
2007
Highly Cited
2007
Preclinical biocompatibility assessment of the EVAHEART ventricular assist device: coating comparison and platelet activation.
Thromboembolism and bleeding remain significant complications of ventricular assist device (VAD) support. Increasing the amount… 
Highly Cited
2007
Highly Cited
2007
Assessment of platelet activation indices using the ADVIATM 120 amongst ‘high‐risk’ patients with hypertension
Background. Platelet activation is involved in the pathogenesis of the thrombotic complications of hypertension. Novel surrogate… 
Highly Cited
2005
Highly Cited
2005
Evaluation of flow cytometric and automated methods for detection of activated platelets in dogs with inflammatory disease.
OBJECTIVE To evaluate platelet surface-associated P-selectin, mean platelet component concentration (MPC), mean platelet… 
Highly Cited
2003
Highly Cited
2003
Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
BACKGROUND Atherosclerotic cardiovascular disease is a major cause of morbidity and mortality in patients with end-stage renal… 
Highly Cited
2001
Highly Cited
2001
Platelet count and parameters determined by the Bayer ADVIA 120 in reference subjects and patients.
In order to study the behaviour of traditional and new platelet parameters determined by the ADVIA 120 Hematology System, five… 
Highly Cited
1999
Highly Cited
1999
Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system.
Platelet activation results in changes in a number of cell surface molecules including an increase in P-Selectin (CD62P) that may… 
Highly Cited
1996
Highly Cited
1996
Improved blood compatibility of segmented polyurethanes by polymeric additives having phospholipid polar groups. I. Molecular design of polymeric additives and their functions.
To improve the blood compatibility of a segmented polyurethane (SPU), 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)